materials-chemistry-2018-scientifictracks

Page 32

Notes:

allied

academies

Journal of Materials Science and Nanotechnology | Volume: 2

August 20-21, 2018 | Paris, France

Materials Science and Materials Chemistry

International Conference on

ART chewing gum: A linkage to care

Rahul Hajare

National AIDS Research Institute, India

he oral effects of HIV and AIDS occur because of your

weakened immune system and the medicines that kept

under control. Theseeffectshavealsofound inotherpeoplewith

weakened immune systems. Dry mouth (xerostomia) because

people with HIV have an increased risk of cavities, a dentist

will provide a program to reduce the risk. This may include

fluoride varnishes applied in the dental office, toothpaste that

add minerals to teeth and rinses that contain fluoride or reduce

acid (acidity of mouth) in the mouth. Patient education has an

essential part of this program. Dry mouth has xerostomia has a

symptomof HIV infectionbut not something thatwouldbe used

as a diagnostic tool. There are many reasons if you have HIV,

changes in the mouth may reflect changes in immune status.

Dry mouth (xerostomia) has a common side effect of medicines

that may take for HIV/AIDS. Dry mouth can make more prone

to tooth decay, gingivitis, thrush (oral yeast infection) and

periodontal (gum) disease. That’s because have less saliva, and

the quality of the saliva is changed exponentially. Besides water,

saliva includes electrolytes, mucus, antibacterial compounds,

enzymes and other proteins. The amounts of these substances

change in people with dry mouth. A decrease in saliva reduces

its ability to wash away sugars, food, bacteria and the acids

that bacteria produce. These acids cause teeth to decay. A

dentist can prescribe a fluoride rinse or gel or a saliva substitute

to counteract the increased risk of tooth decay and thrush.

Speaker Biography

Rahul Hajare is a bright student of the renowned immunologist, R.S.Paranjape, retired

director & Scientist ‘G’ National AIDS Research Institute India. He has completed his PhD

at the age of 32 from Vinayaka Mission University and postdoctoral studies from Indian

Council of Medical Research Delhi. Currently, he is working in the National AIDS Research

Institute Pune on transcutaneous DNA vaccination, Nipah drug delivery systems, new

cancer drug delivery systems and specific antibodies attached drug delivery systems and

DNA vaccination.